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http://dx.doi.org/10.1016/j.stemcr.2016.08.019SUMMARYAdult hippocampal neurogenesis was impaired in several Alzheimer’s disease models overexpressing mutant human amyloid precursor
protein (hAPP). However, the effects of wild-type hAPP on adult neurogenesis andwhether the impaired adult hippocampal neurogenesis
was caused by amyloid b (Ab) or APP remained unclear. Here, we found that neurogenesis was impaired in the dentate gyrus (DG) of adult
mice overexpressingwild-type hAPP (hAPP-I5) comparedwith controls.However, the adult hippocampal neurogenesiswasmore severely
impaired in hAPP-I5 than that in hAPP-J20mice, which express similar levels of hAPPmRNA butmuch higher levels of Ab. Furthermore,
reducing Ab levels did not affect the number of doublecortin-positive cells in the DG of hAPP-J20 mice. Our results suggested that hAPP
was more likely an important factor inhibiting adult neurogenesis, and Ab was not the major factor affecting neurogenesis in the adult
hippocampus of hAPP mice.INTRODUCTION
Neurogenesis occurs in the subgranular zone (SGZ) of the
dentate gyrus (DG) throughout life in the adult brain of
most mammals including human beings (Bond et al.,
2015; Eriksson et al., 1998; Spalding et al., 2013). Newly
generated neurons can be integrated into the pre-existing
neural circuits (Ge et al., 2007; Lledo et al., 2006; Restivo
et al., 2015; Sultan et al., 2015; Tashiro et al., 2006a; van
Praag et al., 2002). Although the physiological roles of
newborn neurons are not fully understood, many studies
indicated that they were involved in the hippocampus-
dependent functions such as learning and memory, mood
regulation, and pattern separation (Christian et al., 2014;
Clelland et al., 2009; Deng et al., 2010; Kang et al., 2016;
Sahay et al., 2011a, 2011b; Shors et al., 2001). The process
of neurogenesis in the adult brain consists of several
stages including proliferation, differentiation, migration,
survival, axonal and dendritic targeting, and synaptic inte-
gration (Ehninger and Kempermann, 2008). Intense efforts
were conducted in the past several years to dissect how the
different stages of neurogenesis were regulated (Bond et al.,
2015). Physical activities such as exercise and an enriched
environment can prompt neurogenesis (Marlatt et al.,
2013; Nilsson et al., 1999; Valero et al., 2011; van Praag
et al., 1999). Stress, aging, and neurological disorders, how-
ever, may inhibit neurogenesis (Richetin et al., 2015;
Winner et al., 2011; Yun et al., 2010; Zhao et al., 2008).Stem Cell R
This is an open access article under the CAlzheimer’s disease (AD) is the most common neuro-
degenerative disorder. The pathological hallmarks of
AD include extracellular amyloid plaques consisting
mainly of Ab42, and intracellular neurofibrillary tangles
comprising mainly hyperphosphorylated tau (Serrano-
Pozo et al., 2011). Previous studies reported that adult hip-
pocampal neurogenesis was affected in AD patients. How-
ever, results fromdifferent groupswere not consistent (Boe-
khoorn et al., 2006; Jin et al., 2004; Li et al., 2008). On the
other hand, it was nearly impossible to investigate system-
atically the effects of AD on different stages of adult neuro-
genesis by using samples from AD patients. Therefore, ani-
mal models simulating key pathological features of AD
provided invaluable tools to study the effects of different
factors involved in AD on adult neurogenesis (Epis et al.,
2010). Transgenic mice overexpressing human amyloid
precursor proteins (hAPP) are common animal models of
AD. Although data from different studies were still contro-
versial, most experimental results indicated that adult
hippocampal neurogenesis was adversely disturbed in
mice with hAPP overexpression (Chuang, 2010; Donovan
et al., 2006; Haughey et al., 2002). However, hAPP-overex-
pressing mice contained higher levels of both hAPP and
amyloid b (Ab) in the brain compared with nontransgenic
controls (Mucke et al., 2000). It remained unknown, there-
fore, whether a high level of hAPP or Ab was the major
factor accounting for impaired adult neurogenesis in these
models. Besides, mice overexpressing mutant hAPP wereeports j Vol. 7 j 707–718 j October 11, 2016 j ª 2016 The Authors. 707
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Figure 1. Wild-Type hAPP Overexpression Reduced the Number
and Impaired the Morphology of Newborn Neurons
(A) Representative photomicrographs of immunohistochemical
staining for BrdU inhAPP-I5 andnontransgenic controls (2.5months
old) at 28 days after the last BrdU injection. BrdU staining is shown
as red; nuclei were labeled by DAPI shown as blue. Scale bar, 100 mm.
(B) Quantification of BrdU-positive cells in the SGZ of dentate gyrus
in hAPP-I5 mice (n = 6, 3 female and 3 male) and nontransgenic
control mice (n = 6, 3 female and 3 male). *p < 0.05 (unpaired
t test); values represent mean ± SEM.
(C, E, and G) Representative photomicrographs of dendrites of
newborn neurons labeled by retrovirus-GFP at 2 weeks post injec-
tion (wpi) (C) and 4 wpi (E), and spine densities of newborn neu-
rons at 4 weeks old (G) in hAPP-I5 and nontransgenic control mice.
Scale bars, 30 mm (C), 50 mm (E), and 5 mm (G).
(D, F, and H) Quantification of total dendritic length per newborn
neuron at 2 wpi (n = 5, female) (D), 4 wpi (n = 3 for control mice,
n = 6 for hAPP-I5 mice, all female mice) (F), and spine densities at
4 wpi (n = 4 for control mice, n = 6 for hAPP-I5 mice, all female
mice) (H) in hAPP-I5 and nontransgenic control mice. *p < 0.05
(unpaired t test); values represent mean ± SEM.
See also Figure S1.
708 Stem Cell Reports j Vol. 7 j 707–718 j October 11, 2016used in most of the studies. The effects of wild-type hAPP,
which is harbored in most sporadic AD patients, on adult
neurogenesis were far from clear.
In the present study, we investigated adult hippocampal
neurogenesis in hAPP-I5mice that overexpressed wild-type
hAPP in neurons driven by platelet-derived growth factor
(PDGF) b-chain promoter. Furthermore, we compared adult
neurogenesis in hAPP-I5 and hAPP-J20 mice. These two
lines of mice expressed similar levels of hAPP mRNA but
very different levels of Ab in the brain (Mucke et al.,
2000). We found that adult hippocampal neurogenesis
was impaired in hAPP-I5 mice. More interestingly, the de-
gree of impairment of neurogenesis was more prominent
in hAPP-I5 mice compared with that of hAPP-J20 mice,
and downregulating Ab levels did not affect the number
of newborn neurons in hAPP-J20 mice, suggesting that
Ab was not the major factor accounting for impaired adult
hippocampal neurogenesis.RESULTS
Adult Hippocampal Neurogenesis Was Impaired in
hAPP-I5 Mice
To test whether adult neurogenesis was affected in hAPP-I5
mice, we injected bromodeoxyuridine (BrdU) intraperito-
neally into 2.5-month-old hAPP-I5 and nontransgenic
control mice. Four weeks later, mice were perfused and
brain sections were analyzed by free-floating immunofluo-
rescence staining using anti-BrdU antibody. The number of
BrdU+ cells was significantly reduced in the hippocampus
of hAPP-I5mice compared with that of nontransgenic con-
trol mice (Figures 1A and 1B). Because hippocampal neural
stem cells can differentiate into neurons and astrocytes,
brain slices from mice injected with BrdU were then co-
immunostained with antibodies against BrdU and NeuN,
a mature neuronal marker. The number of BrdU and
NeuN double-positive cells was also dramatically reduced
in hAPP-I5 mice compared with that of control mice (Fig-
ures S1A and S1B). However, the ratio of BrdU+/NeuN+ to
total BrdU+ cells was similar between hAPP-I5 and control
mice (Figure S1C), suggesting that the differentiation of
neural stem cells to neurons was not affected in hAPP-I5
mice. Taken together, these data indicated that adult hip-
pocampal neurogenesis was impaired in hAPP-I5 mice.
To further examine whether the development of
newborn neurons was affected in the hippocampus of
adult hAPP-I5 mice, we stereotactically injected a murine
Moloney leukemia virus-based retroviral vector expressing
EGFP (Zhao et al., 2006) into the DG to label newly gener-
ated neurons. Retrovirus labeled only dividing cells (Zhao
et al., 2006). Therefore, the day of the injection marked
the birth date of neurons. We analyzed GFP-labeled
Figure 2. Wild-Type hAPP Overexpres-
sion Decreased the Number of Immature
Neurons and Proliferation of Neural Pro-
genitor Cells
(A) Representative photomicrographs of
DCX+ immature neurons in the DG of hAPP-I5
and nontransgenic controlmice (2.5months
old). Scale bar, 100 mm.
(B) Quantification of DCX+ immature neu-
rons in hAPP-I5 mice (n = 7, 4 female
and 3 male) and nontransgenic controls
(n = 6, 3 male and 3 female). *p <
0.05 (unpaired t test); values represent
mean ± SEM.
(C) Representative photomicrographs of
immunostaining for BrdU in hAPP-I5 mice
and nontransgenic controlmice (2.5months
old) at 2 hr after BrdU injection. Scale bar,
200 mm.
(D) Quantification of BrdU+ cells in the DG
of hAPP-I5 mice (n = 5, 3 female and 2 male)
and nontransgenic controls (n = 5, 3 female and 2 male). **p < 0.01 (unpaired t test); values represent mean ± SEM.
(E) Representative photomicrographs of MCM2+ neural progenitors in 2.5-month-old hAPP-I5 and nontransgenic controls. Scale bar,
100 mm.
(F) Quantification of MCM2+ cells in the DG of hAPP-I5 mice (n = 5, 3 female and 2 male) and nontransgenic controls (n = 8, 5 female and
3 male). ***p < 0.001 (unpaired t test); values represent mean ± SEM.newborn neurons at 14 and 28 days post infection (dpi) by
confocal microscopy. At 14 dpi, the newborn neurons were
immature. The cell bodies were located in the SGZ, and
their dendritic processes extended into the granule cell
layer and reached the inner molecular layer. No spines
were observed on the dendritic shafts. We measured the
dendritic length of GFP-labeled immature neurons at this
developmental stage. There was no difference regarding
the dendritic length of new neurons between hAPP-I5
and control mice (Figures 1C and 1D). At 28 dpi, the den-
dritic arborization of newly generated neurons appeared
more elaborated than that at 14 dpi, and their processes
grew into the molecular layer with many of them reaching
the edge of the molecular layer. Spines were frequently
observed on the dendritic branches at this stage. We
measured the spine density and dendritic length of
newborn neurons. Although the spine densities were
similar (Figures 1G and 1H), the dendrites of newborn
neurons from hAPP-I5 were significantly shorter in
comparison with control mice (Figures 1E and 1F). These
data further demonstrated that adult neurogenesis was
impaired in the hippocampus of hAPP-I5 mice.
Neural Progenitor Cell Proliferation and the Number
of Immature NewbornNeurons Decreased in the Adult
Hippocampus of hAPP-I5 Mice
The developmental process of newborn neurons in the
adult hippocampus includes different stages (Ehningerand Kempermann, 2008). To determine whether earlier
developmental stages of newborn neurons were affected,
we quantified the doublecortin (DCX)-positive immature
neurons in the DG of hAPP-I5 and nontransgenic control
mice. We found that DCX-positive neurons were much
fewer in number in the DG of hAPP-I5 mice than in the
DG of control mice (Figures 2A and 2B). We then injected
BrdU intraperitoneally into 2.5-month-old hAPP-I5 and
nontransgenic control mice. Neural progenitor cell prolif-
erationwas examined at 2 hr after BrdU injection by immu-
nostaining using anti-BrdU antibody. Fewer proliferating
cells were observed in the SGZ of hAPP-I5 mice than in
nontransgenic control mice (Figures 2C and 2D). To vali-
date this observation, we perfused a different cohort of
mice and stained the brain slices with an antibody against
MCM2 (minichromosome maintenance type 2), a marker
for proliferation. Similarly, the number of MCM2-positive
cells was significantly decreased in the DG of hAPP-I5
mice (Figures 2E and 2F). These results demonstrated that
neural progenitor cell proliferation and the number of
immature newborn neurons decreased in the adult hippo-
campus of hAPP-I5 mice.
Adult Neurogenesis Was More Significantly Affected
in the DG of hAPP-I5 Mice Than in the DG of
hAPP-J20 Mice
Adult hippocampal neurogenesis was impaired in hAPP-
J20 mice (Sun et al., 2009), a line of transgenic miceStem Cell Reports j Vol. 7 j 707–718 j October 11, 2016 709
Figure 3. Adult-Born Immature Neurons Labeled via POMC-GFP Mice Numbered Fewer in the DG of hAPP-I5 Mice Than in the DG of
hAPP-J20 Mice
(A) Representative photomicrographs of GFP+ immature neurons in the DG of 1-month-old hAPP-I5/POMC-GFP and hAPP-J20/POMC-GFP
mice and their age-matched controls. PG, POMC-GFP; I5/PG, hAPP-I5/POMC-GFP; J20/PG, hAPP-J20/POMC-GFP. Scale bar, 100 mm.
(B) Western blotting bands of GFP expression in 1-month-old hAPP/POMC-GFP mice and age-matched controls. b-Tubulin was used as
loading control.
(C) Quantification of western blots showed no significant changes of GFP expression in both hAPP-I5/POMC-GFP (n = 4, 2 male and 2
female) and hAPP-J20/POMC-GFP mice (n = 3, 2 male and 1 female) compared with their controls (n = 3, 2 male and 1 female). One-way
ANOVA with Newman-Keuls post hoc test; values represent mean ± SEM.
(legend continued on next page)
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overexpressing mutant human APP in neurons driven by
the PDGF b-chain promoter. Levels of both hAPP and Ab
were higher in the brain of hAPP-J20 mice in comparison
with nontransgenic control mice. Therefore, it was not
clear whether the impaired neurogenesis was due to
overexpressed hAPP or Ab. To address this question, we
compared adult hippocampal neurogenesis in the DG
between hAPP-J20 and hAPP-I5 mice. These two lines of
mice expressed similar levels of hAPP mRNA but very
different levels of Ab (Mucke et al., 2000).
To compare the adult hippocampal neurogenesis be-
tween hAPP-I5 and hAPP-J20 mice, we took advantage of
pro-opiomelanocortin (POMC)-GFP mice, a line of trans-
genic mice in which immature neurons (2–3 weeks old)
in the DG could be effectively labeled by GFP (Overstreet
et al., 2004). We crossed hAPP-J20 and hAPP-I5 mice
with POMC-GFP mice to generate offspring to study
GFP-labeled neurons. As shown in Figure 3, GFP-labeled
cells displayed typical morphology of immature neurons.
Their somas were largely located in the SGZ, and the apical
dendrites were short and less elaborated. We found that
there was no difference in the localization of the GFP-
labeled immature neurons in the DG of hAPP-J20, hAPP-
I5 and control mice (Figures 3A, 3D, and 3F), suggesting
that migration of newborn neurons was not affected by
overexpressing either hAPP or Ab. We then quantified
the adult-born immature neurons in the DG in mice of
differing age. At 1 month old, neurogenesis was quite
active, and therefore dense populations of immature neu-
rons were observed in the DG (Figure 3A). Because the
neurons were tightly packed together, it was difficult to
quantify them by direct counting. Considering that GFP
was exclusively expressed in immature neurons in the hip-
pocampus, we sought to quantify the immature neurons
indirectly by determining GFP expression levels in the hip-
pocampus with western blotting analysis. No difference
of GFP expression levels was found in the hippocampus
among hAPP-J20/POMC-GFP, hAPP-I5/POMC-GFP, and
NTG/POMC-GFP mice (Figures 3B and 3C), indicating
that immature neurons in the DG of hAPP-J20 and
hAPP-I5 mice at 1 month of age were not affected in com-(D) Representative photomicrographs of GFP+ immature neurons in the
mice and their age-matched controls. Scale bar, 100 mm.
(E) Quantification of GFP+ immature neurons in the DG of hAPP-I5/PO
3 female and 2 male), and POMC-GFP mice (n = 9, 5 female and 4 male)
Newman-Keuls post hoc test); values represent mean ± SEM.
(F) Representative photomicrographs of GFP+ immature neurons in th
and their age-matched controls. Scale bar, 100 mm.
(G) Quantification of GFP+ immature neurons in the DG of hAPP-I5/PO
female and 4 male), and POMC-GFP mice (n = 10) at 4.5 months old. *p
test); values represent mean ± SEM.
See also Figure S2.parison with control mice. For 2.5-month-old mice, the
number of immature neurons in the DG of hAPP-I5 mice
was reduced to about 30% of control mice. In the DG of
hAPP-J20 mice, however, the degree of reduction of imma-
ture neurons was much smaller (to about 70% of control
mice) (Figures 3D and 3E). Direct comparison between
hAPP-I5 and hAPP-J20 also revealed that there were signif-
icantly more newborn immature neurons in the DG of
hAPP-J20 mice. Similar results were obtained for mice at
4.5 months old (Figures 3F and 3G). To determine whether
overexpression of hAPP affects the GFP expression per se
in POMC-GFP mice, we stained brain sections from
NTG/POMC-GFP and hAPP/POMC-GFP mice with anti-
DCX antibody. Our results showed that the GFP signal
was almost completely aligned with the DCX expression
in the hippocampus of either NTG/POMC-GFP or hAPP/
POMC-GFP mice (Figure S2), suggesting that the reduced
GFP signal in the hippocampus of hAPP/POMC-GFP
mice was due to reduced neurogenesis but not reduced
GFP expression.
To compare the populations of active neural progenitors,
we injected 2.5-month-old hAPP-I5 and hAPP-J20 mice
with BrdU and euthanized them 2 hr later. Quantification
of BrdU+ cells showed that the number of active neural pro-
genitors was significantly decreased in the DG of hAPP-I5
mice compared with that in control mice (Figures 4A and
4B). However, the number of active neural progenitors in
the DG of hAPP-J20 mice was slightly increased compared
with that in the DG of control mice, although it did not
reach statistical significance. Direct comparison revealed
that there were more active neural progenitors in the DG
of hAPP-J20 mice than in the DG of hAPP-I5 mice (Figures
4A and 4B).
During adult hippocampal neurogenesis, many newborn
neurons died before they reached maturation. To compare
the number of mature adult-born new neurons in the DG
between hAPP-I5 and hAPP-J20 mice, we quantified the
number of BrdU+/NeuN+ cells 28 days after the last injec-
tion of BrdU. Our results showed that there were more
mature newborn neurons in the DG of hAPP-J20 mice
than in hAPP-I5 mice (Figures S3A–S3E).DG of 2.5-month-old hAPP-I5/POMC-GFP and hAPP-J20/POMC-GFP
MC-GFP (n = 7, 3 female and 4 male), hAPP-J20/POMC-GFP (n = 5,
at 2.5 months old. **p < 0.01, ***p < 0.001 (one-way ANOVA with
e DG of 4.5-month-old wild-type and mutant hAPP/POMC-GFP mice
MC-GFP (n = 5, 3 female and 2 male), hAPP-J20/POMC-GFP (n = 9, 5
< 0.05, ***p < 0.001 (one-way ANOVA with Newman-Keuls post hoc
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Figure 4. Neural Stem Cells Numbered Fewer in the DG of hAPP-
I5 Mice Than in the DG of hAPP-J20 Mice
(A) Representative photomicrographs of immunostaining for BrdU
in hAPP-I5 and hAPP-J20 mice (2.5 months old) at 2 hr after BrdU
injection. Scale bar, 100 mm.
(B) Quantification of BrdU+ active neural progenitor cells in the DG
of hAPP-I5 (n = 5, 3 female and 2 male) and hAPP-J20 mice (n = 4, 2
female and 2 male). *p < 0.05, **p < 0.01 (one-way ANOVA with
Newman-Keuls post hoc test); values represent mean ± SEM.
See also Figure S3.
Figure 5. hAPP Processing and Ab Levels Were Different in the
Hippocampi of 2.5-Month-Old hAPP-I5 and hAPP-J20 Mice
(A) Hippocampal lysates from hAPP-I5, hAPP-J20, and non-
transgenic control mice were analyzed by western blotting for de-
tecting hAPP (6E10), b-CTF, and a-CTF (CT15). GAPDH severed as
the loading control.
(B) Quantification of western blots showed significantly increased
hAPP, reduced b-CTF, and similar a-CTF levels in the hippocampus
of hAPP-I5 mice compared with those in the DG of hAPP-J20 mice
(n = 4, 2 female and 2 male). ***p < 0.001 (unpaired t test); values
represent mean ± SEM.
(C) Comparison of human Ab1–42 and Ab1–x levels by ELISA in the
hippocampus of mice overexpressing wild-type (hAPP-I5; n = 7,
5 female and 2 male) and mutant hAPP (hAPP-J20; n = 5, 3 female
and 2 male). **p < 0.01, ***p < 0.001 (unpaired t test); values
represent mean ± SEM.
See also Figure S4.Taken together, our data revealed that adult neurogenesis
was suppressed in the DG of both hAPP-J20 and hAPP-I5
mice. However, it was more significantly impaired in the
DG of hAPP-I5 than in the DG of hAPP-J20 mice.
hAPP Processing and Ab Levels Were Different in the
Hippocampi of hAPP-J20 and hAPP-I5 Mice
Although the mRNA levels of hAPP were quite similar be-
tween hAPP-J20 andhAPP-I5mice, it was not clear whether
this was still the case at the protein level. We therefore
analyzed the expression of hAPP protein and its enzymatic
fragments bywestern blotting. Our results revealed that the
hAPP protein level was significantly higher in the hippo-
campus of hAPP-I5 mice than in the hippocampus of
hAPP-J20 mice (Figures 5A, 5B, and S4A–S4C). However,
the b-CTF (b-carboxyl terminal fragment) level was much
lower in hAPP-I5 mice, while the a-CTF (a-carboxyl termi-712 Stem Cell Reports j Vol. 7 j 707–718 j October 11, 2016nal fragment) levels were similar between hAPP-I5 and
hAPP-J20 mice (Figures 5A and 5B). Furthermore, the level
of sAPPb was similar in the hippocampi of hAPP-I5 and
hAPP-J20 mice (Figure S4A), but the level of sAPPa was
significantly higher in the hippocampus of hAPP-I5 mice
than that of hAPP-J20mice (Figure S4B). Collectively, these
data suggested that hAPP was processed differently in
hAPP-I5 and hAPP-J20 mice. We also determined the levels
Figure 6. Reducing Ab Levels Did Not Affect DCX+ Immature
Neurons in the DG of hAPP-J20 Mice
(A) Representative photomicrographs of DCX+ immature neurons in
the DG from 2.5-month-old mice of four genotypes: NTG/CysC+/+,
NTG/CysC/, hAPP-J20/Cysc+/+, and hAPP-J20/Cysc/. CysC,
cystatin C. Scale bar, 50 mm.
(B) Number of DCX+ cells was not changed in hAPP-J20/CST3/
mice (n = 10, 6 female and 4 male) with lower levels of Ab compared
with hAPP-J20/CST3+/+ mice (n = 9, 5 female and 4 male). ns, no
significant difference. **p < 0.01, ***p < 0.001 (one-way ANOVA
with post hoc Tukey’s multiple comparison test); values represent
mean ± SEM.of soluble Ab in the hippocampus of hAPP-I5 and hAPP-J20
mice by ELISA. Consistent with previous reports (Mucke
et al., 2000), levels of both total Ab and Ab42 were indeed
much higher in hAPP-J20 mice than those in hAPP-I5
mice (Figure 5C). Western blot analysis revealed that
oligo-Ab was barely detected in the hippocampus of
hAPP-I5 mice at 2.5 months of age. However, weak bands
of oligo-Ab were observed in the hippocampus of hAPP-
J20 mice at 2.5 months of age (Figure S4C). These data
indicated that differently processed hAPP might account
for the different changes in adult hippocampal neurogene-
sis between hAPP-I5 and hAPP-J20 mice, and that Ab
was not the major factor impairing adult hippocampal
neurogenesis.Reducing Ab Levels Did Not Affect DCX+ Immature
Neurons in the DG of hAPP-J20 Mice
To verify our assumption that Ab was not the major factor
accounting for the impaired adult hippocampal neurogen-
esis, we compared the numbers of DCX+ immature neurons
in the DG between hAPP-J20mice and hAPP-J20mice with
reduced Ab levels. We demonstrated previously that levels
of both total Ab and Ab42 were significantly reduced
(around 45% for total Ab and 60% for Ab42, respectively)
in the hippocampus of hAPP-J20 mice after deleting cysta-
tin C, an endogenous inhibitor of cathepsin B that trun-
cated Ab from the C termini (Mueller-Steiner et al., 2006;
Sun et al., 2008). On the other hand, cystatin C deletion
did not affect the processing of hAPP (Sun et al., 2008).
Taking advantage of these findings, we analyzed the
DCX+ neurons in the DG of NTG/CST3+/+, hAPP-J20/
CST3+/+, NTG/CST3/, and hAPP-J20/CST3/ mice.
CST3 is the gene encoding cystatin C.We found that cysta-
tin C deficiency did not affect the number of DCX+ neu-
rons in the DG of NTGmice (Figures 6A and 6B). However,
DCX+ neurons were much fewer in the DG of hAPP-J20/
CST3+/+ mice compared with NTG mice (Figures 6A and
6B). More interestingly, no difference of DCX+ neurons
was observed in the DG between hAPP-J20/CST3+/+ and
hAPP-J20/CST3/ mice (Figures 6A and 6B), even if the
Ab levels were significantly reduced in the latter mice.
These results further suggested that Ab was not the major
factor accounting for impaired adult hippocampal neuro-
genesis in hAPP-J20 mice.DISCUSSION
Our study showed that high levels of wild-type hAPP
affected different stages of adult hippocampal neurogene-
sis. More importantly, our results suggested that Ab was
not the major factor affecting neurogenesis in the hippo-
campus of adult mice overexpressing hAPP.
Adult hippocampal neurogenesis has been investigated
in different lines of mice overexpressing mutant hAPP
(Chuang, 2010; Donovan et al., 2006; Yu et al., 2009). Sur-
prisingly, however, studies on the effects of wild-type hAPP
on adult neurogenesis have been very rare, considering
that most AD patients did not express the mutant forms
of APP (Soldner and Jaenisch, 2015). In an earlier study,
BrdU-labeling results indicated that a high level of wild-
type hAPP reduced the proliferative ability of progenitor
cells and promoted the survival of newborn neurons in
the DG (Naumann et al., 2010). In our present study, we
used both BrdU labeling and retroviral vector expressing
GFP to investigate the changes in numbers and morpho-
logical features of newborn neurons, respectively. Consis-
tent with a previous report (Naumann et al., 2010), weStem Cell Reports j Vol. 7 j 707–718 j October 11, 2016 713
found that the proliferative activity of progenitor cells in
the DG of hAPP-I5 mice was decreased, as shown by BrdU
labeling and MCM2 immunostaining. By crossing hAPP-
I5 mice with Nestin-GFP mice (a reporter line of neural
stem cells) (Mignone et al., 2004), we found that the deple-
tion of the neural progenitor cell population was acceler-
ated in theDGof hAPP-I5mice (data not shown). Similarly,
neural progenitor proliferation in the DG was increased in
APP knockout mice (Wang et al., 2014). These data sug-
gested that APP from both human and mouse inhibited
the proliferative ability of neural progenitors in the DG.
We found that the number of DCX+ immature neurons
in theDGof hAPP-I5micewas fewer than that in nontrans-
genic control mice. This result was confirmed by crossing
hAPP-I5 with POMC-GFP mice, in which GFP could label
immature neurons in the DG with similarly aged DCX+
neurons (Overstreet et al., 2004). Furthermore, we found
not only that the number of mature newborn neurons
(BrdU+/NeuN+) decreased, but also that the dendrites of
newborn neurons in the DG of hAPP-I5 mice were shorter
than those of control mice. These results indicated that
different developmental stages of adult hippocampal neu-
rogenesis were affected by high levels of wild-type hAPP.
Naumann et al. (2010) reported that the absolute num-
ber of BrdU+ cells at 4 weeks after the last BrdU injection
was similar between hAPP-I5 and control mice, which is
inconsistent with our results. One possibility for this
discrepancy might be the age of mice used in the studies.
Six-week-old mice were used in Naumann’s experiments
whereas we used 10-week-old mice in our study. Neurogen-
esis was more active in younger mice, and therefore the
effect of wild-type hAPP onneurogenesismight be counter-
acted partially by the active neurogenesis in younger mice.
Wang et al. (2014) found that the dendritic growth of
newborn neurons in the DG was significantly reduced in
APP knockout mice, suggesting that both a too low and
too high level of APP were detrimental to the development
of newborn neurons.
Driven by the same promoter, PDGF b-chain, hAPP-I5
mice expressed wild-type hAPP and hAPP-J20 mice ex-
pressed hAPP with Swedish and Indiana mutations in neu-
rons, respectively (Mucke et al., 2000). The expression level
of hAPP mRNA was similar in the brains of hAPP-I5 and
hAPP-J20 mice. However, a previous study (Mucke et al.,
2000) reported that the levels of Ab were much higher in
the brain of hAPP-J20 compared with hAPP-I5 mice, which
we confirm in the present study.We found that the impair-
ment of adult hippocampal neurogenesis was more prom-
inent in hAPP-I5mice than that of hAPP-J20mice, suggest-
ing that Ab was not the major factor accounting for the
impairment of adult neurogenesis. We also found that
hAPP-J20 mice expressedmore oligomeric Ab in the hippo-
campus in comparison with hAPP-I5 mice, further suggest-714 Stem Cell Reports j Vol. 7 j 707–718 j October 11, 2016ing that Abwas not a main factor in the inhibition of adult
neurogenesis. In a niche presented with a high level of Ab,
the proliferation, determination, and survival of hippo-
campal adult-born neurons were not affected (Yetman
and Jankowsky, 2013), also suggesting that Ab was not
themajor culprit for the impairment of adult neurogenesis.
Retroviral delivery of a-CTF into neural progenitors
affected the development of newborn neurons (Morgen-
stern et al., 2013), further suggesting that Ab production
was not necessary to inhibit adult hippocampal neurogen-
esis. Our results showed that downregulating Ab levels by
crossing hAPP-J20 mice with CST3/ mice did not result
in changes in adult hippocampal neurogenesis, providing
more direct and convincing evidence that Ab was not
responsible for impaired adult hippocampal neurogenesis
in both hAPP-I5 and hAPP-J20 mice used in our study.
Although comparable levels of hAPP mRNA were de-
tected in the brain of hAPP-I5 and hAPP-J20mice, our west-
ern blotting analysis revealed that hAPP-I5 mice expressed
significantly higher levels of hAPP protein, lower levels of
b-CTF, and similar levels of a-CTF in the hippocampus
and cortex compared with hAPP-J20 mice, suggesting
that overexpressed hAPP but not Ab might inhibit adult
neurogenesis. Additional analysis of the fragments of
hAPP revealed a higher level of sAPPa in the hippocampus
of hAPP-I5 mice, but the level of sAPPb was similar in the
hippocampi of hAPP-I5 and hAPP-J20 mice, suggesting
that sAPPa but not sAPPb could also be involved in
impaired adult neurogenesis in APP mice.
Because hAPP gene expression was driven by the PDGF
b-chain promoter, hAPP could be derived from different
types of neurons in both hAPP-I5 and hAPP-J20 mice.
Therefore, it was unclear as to which sources of hAPP
were to blame for the impaired adult neurogenesis. Recent
studies showed that overexpression of hAPP exclusively in
mature projection neurons in the forebrain did not affect
neurogenesis in the adult hippocampus (Yetman and Jan-
kowsky, 2013), whereas overexpression of hAPP in neural
progenitor cells via retroviral delivery significantly affected
the morphology and function of adult-born new neurons
in the DG (Morgenstern et al., 2013), suggesting a cell-
autonomous effect of APP on adult neurogenesis. However,
we could not exclude the possibility that other sources of
APP from either GABAergic neurons or even glial cells
would affect adult neurogenesis. In fact, selective deletion
of APP in GABAergic interneurons affected different pro-
cesses of adult hippocampal neurogenesis (Wang et al.,
2014). Further studies are warranted to dissect the defini-
tive factor(s) affecting adult neurogenesis in hAPP-overex-
pressing mice.
In conclusion, our data demonstrated that different
stages of adult hippocampal neurogenesis were disturbed
in mice overexpressing wild-type hAPP, and Ab was not
the major factor accounting for impaired neurogenesis
in the adult hippocampus of APP-overexpressing mice.
However, further studies are needed to investigate the ef-
fects and mechanisms of different hAPP fragments from
different resources in adult hippocampal neurogenesis.EXPERIMENTAL PROCEDURES
Animals
hAPP-I5 mice were purchased from the Jackson Laboratory (stock
#004662). hAPP-J20 mice were purchased from the JAX MMRRC
(stock #034836). hAPP-I5 mice express wild-type human APP
driven by PDGF b-chain promoter. hAPP-J20 mice express an
hAPP minigene with the Swedish (K670N, M671L) and Indiana
(V717F) mutations under the control of PDGF b-chain promoter
(Mucke et al., 2000). The mRNA level of hAPP in hAPP-I5 mice
was comparable with that in hAPP-J20 mice. However, the Ab
levels in hAPP-I5 mice were much lower than those in hAPP-J20
mice (Mucke et al., 2000). Both hAPP-I5 and hAPP-J20 mice lines
were bred with C57BL/6J females to generate offspring for studies.
Age- and sex-matched nontransgenic (NTG) mice were used as
controls. POMC-GFPmice were obtained fromMuming Poo (Insti-
tute of Neuroscience, Chinese Academy of Sciences), respectively.
CST3/ mice were provided by Dr. Anders Grubb (Department
of Clinical Chemistry, Lund University Hospital). All mice were
maintained on a C57BL/6J background except CST3 genetically
removed mice (CST3/). CST3/ mice have 57% C57BL/6J and
43% 129 background. All studies were gender balanced. Animals
were housed in a pathogen-free barrier facility with a 12:12-hr
light/dark cycle and ad libitum access to food and water. All exper-
iments were approved by the Institutional Animal Care and Use
Committee of Zhejiang University.
BrdU Labeling
BrdU (B5002, Sigma) was dissolved in PBS to a concentration of
10 mg/mL and the aliquots were stored at 20C. For cell prolifer-
ation analysis, BrdU (200 mg/kg) was injected intraperitoneally
once and animals were perfused 2 hr later. For cell-survival anal-
ysis, BrdU (100 mg/kg) was injected intraperitoneally twice a day
at 6-hr intervals for 3 consecutive days. Mice were perfused at
28 days after the last injection. For comparing the BrdU-labeled
cells between hAPP-I5 and controls, hAPP-I5 mice and their non-
transgenic controls were treated together (BrdU injection, perfu-
sion, and microtome sectioning), and immunostaining was done
together. For comparison between hAPP-I5 and hAPP-J20, hAPP-
I5 mice, nontransgenic controls of hAPP-I5, hAPP-J20, and non-
transgenic controls of hAPP-J20 mice were treated together (BrdU
injection, perfusion, and microtome sectioning), and immuno-
staining was done together.
Preparation and Stereotactic Injection of Retroviral
Vectors Expressing GFP
Retrovirus-expressing GFP was prepared as described previously
(Tashiro et al., 2006b). In brief, a murine Moloney leukemia vi-
rus-based retroviral vector (CAG-EGFP, kindly provided by Fred
Gage, Salk Institute)was cotransfectedwith pCMV-vsv-g (envelopevector) and pCMV-gag pol into HEK293T cells with Lipofectamine
2000 (11668-019, Invitrogen). HEK293T cells were maintained in
DMEM (11965, Gibco) without antibiotics before transfection. At
5 hr after plasmid transfection, culture medium was changed to
DMEM with antibiotics. Culture medium was then collected
48 hr later and concentrated by ultracentrifugation. Viral pellets
were dissolved in PBS and the aliquots were stored at 80C. For
labeling of adult-born new neurons, viral solution (3 mL) was deliv-
ered into the DG of 2.5-month-old mice by stereotactic injection
(0.5 mL/min) bilaterally with the following coordinates (Paxinos
and Franklin, 2004): anterior-posterior, 2.1 mm; medial-lateral,
±1.7 mm; and vertical, 2.0 mm. For all injections, the bregma
served as the reference point.Immunofluorescence Staining and Counting
Mice were perfused transcardially with 0.9% saline. Brains were
removed immediately and immersed into 4%paraformaldehyde so-
lution. Coronal brain sections (30 mm)were prepared with a sliding
microtome (Leica). Free-floating brain sections were first blocked
with blocking buffer (10% serum, 1% nonfat milk, 0.2% gelatin
in PBS containing 0.5% Triton X-100) and then incubated with
primary antibodies: rabbit anti-GFP (1:500 dilution; A11122,
Invitrogen), goat anti-DCX (1:100 dilution; SC-8806, Santa Cruz
Biotechnology), mouse anti-NeuN (1:1,000 dilution; MABN140,
Millipore),mouse anti-BrdU (1:200 dilution; 11170376001, Roche),
mouse anti-MCM2 (1:200 dilution; 610701, BD Biosciences), fol-
lowed by incubation with appropriate secondary antibodies:
donkey anti-rabbit 488 (1:250 dilution; 711-545-152, Jackson Labo-
ratory), donkey anti-goat cy3 (1:250 dilution; 705-165-147, Jackson
Laboratory), and donkey anti-mouse cy3 and 594 (1:250 dilution;
715-165-150 and 715-585-150, Jackson Laboratory). All images of
dendritic structures were obtained from CAG-EGFP-injected brains
stained with GFP antibody to amplify the GFP signal. For BrdU and
MCM2 staining, sections were pretreated with 2 N HCl at 37C
for 30 min, washed in 0.1 M borate buffer (pH 8.5) for 10 min,
then washed in TBS + Tween 20 (TBST)-Triton (10 mM Tris-HCl
[pH 7.4], including 150mMNaCl, 0.05% Tween 20, and 1% Triton
X-100) for 30 min at room temperature before incubation with
blocking buffer (10% serum in 0.05% TBST).
Cells in the DG were quantified blindly in every tenth serial cor-
onal section (30 mm in thickness) through a 403 objective,
throughout the rostrocaudal extent of the granule cell layer. Eight
coronal sections were analyzed per mouse, and the counted
numbers were then multiplied by 10 to calculate group means.Confocal Image Analysis
For dendritic length analysis, z-series stacks of optical images were
obtained at 2-mm intervals with a confocal microscope (LSM510
Meta, Zeiss). For dendritic spine density analysis, z-series stacks
of optical images were obtained at 0.5-mm intervals with a confocal
microscope (FV1000). Two-dimensional projections of each z se-
ries were created with ImageJ. All individual GFP-positive granule
cells that had continuous dendritic trees were analyzed for total
dendritic length. The total dendritic length of all individual GFP-
positive granule cells was measured with ImageJ. The length of
each dendritic segment was measured by tracing the center of
the dendritic shaft with ImageJ. The number of spines was countedStem Cell Reports j Vol. 7 j 707–718 j October 11, 2016 715
manually by ImageJ. The spine density was calculated by dividing
the total number of spines by the length of the dendritic segment.
Western Blotting Analysis
Cortical and hippocampal samples were homogenized and soni-
cated at 4C in RIPA buffer containing 10 mM HEPES (pH 7.4),
150mMNaCl, 50mMNaF, 1mMEDTA, 1mMDTT, 1mMphenyl-
methylsulfonyl fluoride, 1mMNa3VO4, 10 mg/mL leupeptin, 10mg/
mLaprotinin, and1%SDS.Equal amountsofprotein (byBCAassay)
were resolved by SDS-PAGE and transferred to nitrocellulose mem-
branes. After blocking, membranes were labeled with mouse anti-
tubulin (1:5,000 dilution; KM9003, Sungene Biotech), rabbit anti-
CT15 antibody (1:1,000 dilution; a kind gift of E.H. Koo, University
of California, San Diego) for C-terminal fragments of APP, 6E10
(1:1,000dilution; SIG39320,Covance) forAPPand sAPPa, amixture
of 266, 21F12, and3D6 (1:1,000dilution; JanssenResearch&Devel-
opment) for oligo-Ab, anti-APP C-terminal antibody (1:5,000 dilu-
tion; 171610, Millipore) for APP and sAPPb, or rabbit anti-GAPDH
antibody (1:5,000 dilution; 5174S, CST), and then incubated with
the following secondary antibodies: horseradish peroxidase-conju-
gated goat anti-rabbit antibody (GAR007, LiankeBio) and goat
anti-mouse antibody (GAM007, LiankeBio) of appropriate dilution
ratio. Bands were visualized by enhanced chemiluminescence,
and the densitometry measurements of the bands were acquired
from scanned images with Quantity One software (Bio-Rad).
Quantification of Ab
hAPP-I5 and hAPP-J20 mice (around 2.5 months old) were
perfused transcardially with PBS. Brains were removed immedi-
ately and the hippocampiwere dissected out and placed into liquid
nitrogen. Samples were stored at80Cuntil analysis. Snap-frozen
hippocampi were homogenized in guanidine buffer, and soluble
human Ab peptides were measured by ELISA as described previ-
ously (Johnson-Wood et al., 1997). EIA plates (96 wells; Corning)
were coated with 266 (for Ab1–x) and 21F12 (for Ab1–42), respec-
tively. Biotin-3D6 was used as detection antibody. 266, 21F12,
and 3D6 were provided by Janssen Research & Development.
The Ab1–42 ELISA only detects Ab1–42, whereas Ab1–x ELISA
detects Ab1–40, Ab1–42, and Ab1–43, as well as C-terminally trun-
cated forms of Ab containing amino acids 1–28.
Statistical Analysis
Statistical analyses were conducted with GraphPad Prism 5.
Differences between two means were assessed with an unpaired
two-tailed t test. Differences between three or more means were
assessed by one-way ANOVA. Only values with p < 0.05 were
accepted as significant.
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